Schedule 13D ownership disclosure
REVIVA PHARMACEUTCLS HLDGS I
Security class unavailable · CUSIP: 76152G100
Event date: 2023-04-25
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,811,545
- Percent of class
- 13.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001437749-23-012831
- Form type
- SC 13D
- Filer
- Bhat Laxminarayan
- CIK
- CIK 1818245
- Filed
- May 05, 2023
- Reporting period
- Apr 25, 2023
- Description
- Schedule 13D beneficial ownership